Content about Pharmaceuticals policy

February 11, 2010
Investors should remember the patent cliff

Some investors quoted in published reports foresee huge gains for such retail pharmacy chains as...

WHAT IT MEANS AND WHY ITS IMPORTANT Some investors quoted in published reports foresee huge gains for such retail pharmacy chains as CVS and Walgreens, as blockbuster drugs like Pfizer’s Lipitor (atorvastatin) and Sanofi-Aventis’ and Bristol-Myers Squibb’s Plavix (clopidogrel bisulfate) come off patent and face generic competition, but they would do well to remember an important factor: the patent cliff.

February 10, 2010
PricewaterhouseCoopers projects expansion of retail clinics, offerings

Traditional care delivery models will continue to give way to alternative care delivery models, such...

February 9, 2010
Mylan distribution center receives VAWD accreditation

A Mylan distribution center has received Verified-Accredited Wholesale Distributors accreditation from the National Association of...

February 7, 2010
Amneal receives FDA approval for generic painkiller

Amneal Pharmaceuticals has received approval from the Food and Drug Administration to manufacture a generic...

February 7, 2010
Teva settles drug price inflation lawsuit

Teva Pharmaceutical Industries has reached a settlement in a case alleging that governments had to...

February 1, 2010
Cephalon to buy Swiss drug maker Mepha

Cephalon plans to buy a generic drug maker based in Switzerland for $590 million, the...

February 1, 2010
FDA accepts approval application for Teva's Neutroval

The Food and Drug Administration has accepted a regulatory approval application from Teva Pharmaceutical Industries...

January 31, 2010
ECRM Generics 2010

With the defeat of Democrat Martha Coakley by Republican Scott Brown in the race to fill the seat of late Massachusetts Sen. Ted Kennedy, and the loss of the Democrats’ filibuster-proof majority in the Senate, the healthcare-reform bill stands on a knife’s edge. And how will pharmacies be reimbursed for dispensing generic drugs to Medicaid and Medicare patients if a health overhaul bill fails to pass? These topics, along with the issue of patent settlements vexing the branded and generic drug industries and a new GAO study showing that drug costs are soaring, are explored in depth in the latest installment of the ECRM Generics report.

With the defeat of Democrat Martha Coakley by Republican Scott Brown in the race to fill the seat of late Massachusetts Sen. Ted Kennedy, and the loss of the Democrats’ filibuster-proof majority in the Senate, the healthcare-reform bill stands on a knife’s edge. And how will pharmacies be reimbursed for dispensing generic drugs to Medicaid and Medicare patients if a health overhaul bill fails to pass?

January 31, 2010
FDA seeks budget increase from Obama administration

The Food and Drug Administration hopes to “transform” its oversight of medical product and food...

January 28, 2010
FDA approves generic version of GoLytely

The Food and Drug Administration has approved a generic version of a prescription laxative made...

January 28, 2010
Lupin receives FDA approval for hypertension generic

The Food and Drug Administration has given approval to a generic version of a drug...

January 28, 2010
NCPA backs federal employee benefits bill, makes recommendations

In a letter to Rep. Stephen Lynch, D-Mass., the National Community Pharmacists Association’s chief executive...

January 24, 2010
Report; N.Y. seeks to prohibit doctors from accepting gifts from drug companies

New York Gov. David Paterson hopes to put an end to gifts from drug companies...

January 21, 2010
PhRMA to review efficacy of drugs in study

Several drug makers and an industry trade group representing them will fund a two-year study...

January 20, 2010
Teva receives tentative approval for breast cancer drug

The Food and Drug Administration has given tentative approval to Teva Pharmaceutical Industries for its...

January 19, 2010
Governors urge preservation of current biosimilars legislation

Six governors are hoping to thwart an attempt by the Obama administration to eliminate language...

January 19, 2010
Report: Pfizer, Teva vie for German generic drug maker

Two drug companies are in a race to buy a German generic drug maker, according...

January 18, 2010
HealthWarehouse.com, Atlantis Health Plan provide members with free 90-day supplies of generics

A licensed online pharmacy and a health insurer are collaborating to provide members with 90-day...

January 18, 2010
Watson files application for Lidoderm generic

Watson Pharmaceuticals has filed for regulatory approval of a generic version of a pain drug...

January 14, 2010
Senators push for 12-year exclusivity model for biosimilars

As the House and Senate fuse their respective healthcare-reform bills into one, a push has...

January 13, 2010
FTC seeks law against 'pay-for-delay' deals

The chairman of the Federal Trade Commission and several members of Congress are calling for...

January 13, 2010
Pharmacy groups urge changes to long-term care mandate in health-reform bill; offer alternatives

Two independent community pharmacy advocates are urging Congress to consider more practical alternatives to legislation...

January 13, 2010
The Biggest Little Pharma in the World: Teva gets an “A” rating from Moody’s

Moody’s Investors Service announced Wednesday that it had upgraded the ratings of generic drug maker...

January 12, 2010
GAO: Branded drug prices on the rise

Prices of 416 branded drugs dramatically rose between 2000 and 2008, according to a recent...

January 12, 2010
Teva projects outlook of $31 billion in revenue by 2015

Teva hopes to garner revenues of $31 billion and net income of $6.8 billion by...